Filter
450
Text search:
Artemisinin
Featured
Recommendations
31
New Publications
185
Language
Document type
No document type
264
Studies & Reports
73
Guidelines
43
Strategic & Response Plan
21
Manuals
19
Training Material
10
Fact sheets
10
Resource Platforms
7
Situation Updates
2
Brochures
1
Countries / Regions
Global
26
Liberia
21
Kenya
21
Sierra Leone
20
Uganda
20
Tanzania
15
Myanmar / Burma
15
Nigeria
14
Senegal
14
Ghana
14
Rwanda
13
Malawi
13
Africa
13
India
11
Ethiopia
10
Zambia
9
Zimbabwe
8
Cambodia
8
Cameroon
7
Indonesia
7
South Africa
7
Bangladesh
7
Madagascar
7
Nepal
6
Latin America and the Carribbean
5
Burkina Faso
4
Congo, Democratic Republic of
4
Mozambique
4
Benin
4
South–East Asia Region
4
Vietnam
4
Guinea
3
Mali
3
Thailand
3
North America
3
Philippines
2
Somalia
2
China
2
Namibia
2
Botswana
2
Asia
2
Laos
2
Haiti
1
Lebanon
1
Chad
1
Papua New Guinea
1
Sudan
1
Eswatini/ Swaziland
1
North Macedonia
1
Switzerland
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Paraguay
1
Venezuela
1
Timor Leste/ East Timor
1
Turkmenistan
1
France
1
Authors & Publishers
Publication Years
Category
Countries
280
Clinical Guidelines
30
Public Health
28
Capacity Building
13
Women & Child Health
11
Pharmacy & Technologies
9
Key Resources
8
Toolboxes
Malaria
87
AMR
17
Pharmacy
17
NTDs
7
Global Health Education
6
Health Financing Toolbox
6
Ebola & Marburg
4
HIV
4
Caregiver
4
COVID-19
3
TB
2
Planetary Health
2
NCDs
2
Conflict
1
The document “Malaria Elimination Programme Review, India 2022”, published by the WHO Country Office for India, provides an in-depth assessment of India’s progress toward malaria elimination. It evaluates the structure, implementation, and effectiveness of national and subnational malaria prog
...
The "Regional Action Plan 2017–2030: Towards a Malaria-Free South-East Asia Region" by the World Health Organization (WHO) outlines a strategic framework to eliminate malaria in the 11 countries of the WHO South-East Asia Region by 2030. It focuses on reducing transmission, particularly of Plasmod
...
World malaria report 2024
recommended
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated
...
Insufficient funding is hindering the achievement of malaria elimination targets in Africa, despite the pressing need for increased investment in malaria control. While Western donors attribute their inaction to financial constraints, the global health community has limited knowledge of China’s ex
...
The Plan subscribes to the goals and pillars of the WHO Global Technical Strategy against Malaria 2016-2030 (GTS), while presenting key elements to address the specific challenges of the Region.
Esta nota técnica busca guiar a los programas nacionales de malaria y a las organizaciones implicadas en el apoyo de los esfuerzos para la eliminación de la malaria en la Región de las Américas, a fin de que intensifiquen las acciones políticas/estratégicas e implementen los cambios operativos
...
The Malaria Ministerial Conference, co-hosted by WHO and the Government of Cameroon on 6 March 2024, brought together more than 400 stakeholders, including Ministers of Health and senior representatives from the African countries hardest hit by malaria, global health leaders, scientists, civil socie
...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and
...
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
The Social and Behaviour Change Communication (SBCC) Strategy for the Prevention of the Re-establishment of Malaria Transmission in Timor-Leste forms part of the National Strategic Plan (NSP) for 2021–2025. The strategy aims to support Timor-Leste's efforts to sustain malaria elimination by promot
...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), which is funded by USAID and based at the Johns Hopkins Center for Communication Programs, offers structured guidance for improving social and behavioural change communication (SBCC) strategies relat
...
Social and Behaviour Change Communication (SBCC) is essential for the effective control, prevention and elimination of malaria. The 2018–2030 Strategic Framework for Malaria SBCC guides countries and partners in strengthening capacities, refining strategies and sharing best practices, all of which
...
This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress in combating pediatric malaria, advocating for conti
...
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-frie
...
Report of a virtual meeting 21–23 June 2022
Community led-monitoring is based on the principle that «Nothing that is done for us should
be done without us”. The combination of this principle with evidence shows that community-led
monitoring is an important driver of improved service delivery and health outcomes that needs to
be re-empha
...
Pillar 3 of the Global technical strategy for malaria 2016–2030 calls for the transformation of malaria surveillance into a core intervention in all malaria-endemic countries, as well as in countries which have eliminated malaria but remain susceptible to re-establishment of transmission. This ref
...
Clinical Pharmacology: Advances and Applications, 2025:17 29–47
Preferred product characteristics and clinical development considerations
